QuadMel 2 – Honey Sachet

(Sildenafil / Vardenafil / Tadalafil / Apomorphine)

Available Dosage Strengths

15 mg / 15 mg / 15 mg / 2 mg

Want to Prescribe?

Disclaimer: Images are for reference only; actual products may vary.

Product Overview

Sildenafil / Vardenafil / Tadalafil / Apomorphine Description

This product is a sublingual formulation may be used to enhance genital blood flow and sexual desire in people that are experiencing sexual dysfunction.

Sildenafil1-3 

Sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, has a half-life of 4 hours. Clinically, the drug is used to treat erectile dysfunction and pulmonary hypertension. It also has shown to be beneficial for female sexual arousal disorder. Orally, because of the half-life, the drug is used “on-demand” prior to sexual activity.

Tadalafil4-6

Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, has a mean terminal half-life of over 17 hours. This half-life is much longer than other PDE-5 inhibitors. This half-life allows for once-daily or on-demand dosing. The drug is indicated for the treatment of pulmonary arterial hypertension (PAH), erectile dysfunction (ED), benign prostatic hypertrophy (BPH), or the concurrent treatment of ED and BPH.

Vardenafil7-9 

Vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor, has a mean terminal half-life of 4 to 6 hours. It is effective and generally well tolerated. Vardenafil is a potent and highly selective oral PDE5 inhibitor. The drug is indicated for erectile dysfunction and it is used for on-demand use for this indication.

Apomorphine10-13

Apomorphine is a dopamine receptor agonist that works in the brain (centrally) for erectile dysfunction. The drug improves the penis’s erectile response to stimuli.   It has also been studied to enhance sexual motivation, desire and arousal especially for women. The onset of action is within 30 minutes. The drug is given sublingually to bypass absorption in the gastrointestinal tract and to prevent first pass metabolism in the liver. This will improve blood levels. The duration of activity of apomorphine is 60- 90 minutes with a half-life of approximately 100 minutes.

References

  1. Sildenafil Prescribing Information – Pfizer. www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf Revised March 2014. Accessed May 31, 2025
  2. Clinical Pharmacology Sildenafil clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  3. Smith BP, Babos M. Sildenafil. [Updated 2023 Feb 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558978/ 
  4. Tadalafil Prescribing Information – Eli Lilly. www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf Revised October 2011. Accessed May 31, 2025
  5. Clinical Pharmacology Tadalafil clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  6. Padda IS, Tripp J. Phosphodiesterase Inhibitors. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559276/
  7. Clinical PharmacologyVardenafil clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  8. Vardenafil package insert. Bayer Healthcare Pharmaceuticals, Inc. Revised April 2014. Accessed June 12, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s017lbl.pdf.
  9. Keating GM, Scott LJ. Vardenafil: a review of its use in erectile dysfunction. Drugs. 2003;63(23):2673-703.
  10. Hagemann JH, Berding G, Bergh S, Sleep DJ, Knapp WH, Jonas U, Stief CG. Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction. Eur Urol. 2003 Apr;43(4):412-20.
  11. Caruso S, Agnello C, Intelisano G. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology, 63, 955-959.
  12. Melis MR, Sanna F, Argiolas A. Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review. Brain Sci. 2022 Jun 24;12(7):826.
  13. Clinical Pharmacology Apomorphine clinical monograph 2026 https://www.clinicalkey.com/pharmacology/

Sildenafil1-3 

Phosphodiesterase (PDE) has many isoforms and is an enzyme that has many functions in the body including degrading the effect of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). PDE5 is an enzyme that is found in many parts of the body including in the smooth muscle of the corpus cavernosum, prostate, bladder, the vascular and visceral smooth muscle, skeletal muscle, urethra, platelets, kidney, lung, cerebellum, heart, liver, testis, seminal vesicle, and pancreas. Sildenafil is structurally similar to cGMP and prevents degradation of cGMP by competitively binding and inhibiting activity of PDE5. When PDE5 is inhibited, cGMP accumulates and leads to smooth muscle relaxation.

Tadalafil4-6

Phosphodiesterase (PDE) has many isoforms and is an enzyme that has many functions in the body including degrading the effect of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). PDE5 is an enzyme that is found in many parts of the body including in the smooth muscle of the corpus cavernosum, prostate, bladder, the vascular and visceral smooth muscle, skeletal muscle, urethra, platelets, kidney, lung, cerebellum, heart, liver, testis, seminal vesicle, and pancreas. Tadalafil is a selective inhibitor of PDE5, the enzyme responsible for the degradation of cGMP. The drug has selective activity on PDE5 than other phosphodiesterase isoforms. Tadalafil activity on PDE5 is more than 10,000-fold more than for PDE1, PDE2, PDE4, and PDE7 enzymes. Increased cGMP leads to smooth muscle relaxation in the corpus cavernosum which can help in maintaining an erection.

Vardenafil7-9

Phosphodiesterase (PDE) has many isoforms and is an enzyme that has many functions in the body including degrading the effect of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). PDE5 is an enzyme that is found in many parts of the body including in the smooth muscle of the corpus cavernosum, prostate, bladder, the vascular and visceral smooth muscle, skeletal muscle, urethra, platelets, kidney, lung, cerebellum, heart, liver, testis, seminal vesicle, and pancreas. Vardenafil is a selective inhibitor of PDE5, the enzyme responsible for the degradation of cGMP. Vardenafil’s activity on PDE5 has been shown to be approximately 10 fold to 25 fold more than sildenafil. Increased cGMP leads to smooth muscle relaxation in the corpus cavernosum which can help in maintaining an erection.

Apomorphine10-12

Apomorphine is a dopamine receptor agonist that has activity on dopamine-1 and dopamine-2 receptors in the hypothalamus. The hypothalamus (specifically the paraventricular nucleus (PVN)) has abundant dopamine receptors. The dopamine stimulation in the PVN may have several effects including increasing nitric oxide synthase to stimulate nitric oxide. Nitric oxide stimulates oxytocin which moves through the spinal cord to stimulate a genital blood flow. Increases in dopamine, one of the primary neurotransmitters involved in sexual function, may stimulate sexual desire, motivation and arousal.

Common1-8,13

Sildenafil 

  • Flushing
  • Dyspepsia
  • Nasal congestion
  • Dizziness

Tadalafil

  • Headache
  • Dyspepsia
  • Flushing
  • Back pain and myalgia (typically delayed onset, resolving within 48 hours)
  • Nasal congestion
  • Pain in limbs

Vardenafil

  • Headache
  • Flushing
  • Rhinitis
  • Dyspepsia, vomiting
  • Dizziness

Apomorphine

  • Nausea and vomiting
  • Chest pain
  • Hypotension

Contraindications1-8,13

  • Known hypersensitivity or intolerance to sildenafil, tadalafil, vardenafil or apomorphine
  • Use of nitrates and alpha-blockers due to risk of life-threatening hypotension

Precautions1-8,13

  • Use with caution in patients with:
  • Severe hepatic impairment (Child-Pugh Class C)
  • Severe renal impairment (creatinine clearance <30 mL/min)
  • History of NAION (non-arteritic anterior ischemic optic neuropathy)
  • Recent history of myocardial infarction, stroke, or unstable angina
  • Taking with antihypertensives and antiemetics
  • Store at controlled room temperature (20°C to 25°C / 68°F to 77°F)
  • Protect from moisture and light
  • Keep in a tightly closed container
  1. Sildenafil Prescribing Information – Pfizer. www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf Revised March 2014. Accessed May 31, 2025
  2. Clinical Pharmacology Sildenafil clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  3. Smith BP, Babos M. Sildenafil. [Updated 2023 Feb 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558978/ 
  4. Tadalafil Prescribing Information – Eli Lilly. www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf Revised October 2011. Accessed May 31, 2025
  5. Clinical Pharmacology Tadalafil clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  6. Padda IS, Tripp J. Phosphodiesterase Inhibitors. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559276/
  7. Clinical PharmacologyVardenafil clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  8. Vardenafil package insert. Bayer Healthcare Pharmaceuticals, Inc. Revised April 2014. Accessed June 12, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s017lbl.pdf.
  9. Keating GM, Scott LJ. Vardenafil: a review of its use in erectile dysfunction. Drugs. 2003;63(23):2673-703.
  10. Hagemann JH, Berding G, Bergh S, Sleep DJ, Knapp WH, Jonas U, Stief CG. Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction. Eur Urol. 2003 Apr;43(4):412-20.
  11. Caruso S, Agnello C, Intelisano G. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology, 63, 955-959.
  12. Melis MR, Sanna F, Argiolas A. Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review. Brain Sci. 2022 Jun 24;12(7):826.
  13. Clinical Pharmacology Apomorphine clinical monograph 2026 https://www.clinicalkey.com/pharmacology/

This information is for educational purposes only.

This compounded product has not been reviewed, approved, or evaluated by the Food and Drug Administration for safety and effectiveness. This product is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding treatment, cure, or prevention of any disease or condition.

This information is a summary. It may not cover all possible drug information about this product. Call your doctor for medical advice and/or about side effects. You may report side effects to the FDA at 1-800-FDA-1088.  A Wells Pharmacy Network pharmacist will be happy to answer any questions. For consultation, please call 1-800-622-4510.

EXPLORE MORE

Featured Medications

We deliver your orders fast and with complete discretion, straight to your door.

We're licensed to ship nationwide

Our mission is to elevate compounding industry standards through a unique combination of superior science and service.

Ready to get started?